1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Dysembryoma in 1 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, YL | 1 |
Chen, SJ | 1 |
Kao, CL | 1 |
Hung, SC | 1 |
Ding, DC | 1 |
Yu, CC | 1 |
Chen, YJ | 1 |
Ku, HH | 1 |
Lin, CP | 1 |
Lee, KH | 1 |
Chen, YC | 1 |
Wang, JJ | 1 |
Hsu, CC | 1 |
Chen, LK | 1 |
Li, HY | 1 |
Chiou, SH | 1 |
1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Dysembryoma
Article | Year |
---|---|
Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Cells, Cultured; Docosahexaenoic A | 2012 |